Share Email Print

Proceedings Paper

Fluorescence-based SMC and OCT endoscope to study aberrant crypt foci in the mouse colon
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The accepted model of colorectal cancer assumes the paradigm that aberrant crypt foci (ACF) are the earliest events in tumorigenesis and develop into adenoma, which further develop into adenocarcinoma. Under this assumption, basic research and drug studies have been performed using ACF as substitute markers for fully developed carcinoma. While studies have shown a correlation between the number of ACF present and the presence of adenoma/adenocarcinoma, a causal relationship has yet to be determined. The mouse has shown to be an excellent model for colorectal cancer; however, the outcomes of such experiments require sacrifice and histologic examination of ex vivo tissue. To better utilize the mouse model to study ACF and adenoma development, an endoscope was constructed for non-destructive in vivo surface visualization, molecular imaging and cross-sectional imaging of the colon. Our system combines surface magnifying chromoendoscopy (SMC) and optical coherence tomography (OCT) to image colon microstructure. Sixteen mice, treated with the carcinogen azoxymethane, were imaged at 2 week intervals, to visualize carcinogenesis events. With this dual-modality system we are able to visualize crypt structure alteration over time as well as adenoma development over time.

Paper Details

Date Published: 13 March 2013
PDF: 7 pages
Proc. SPIE 8575, Endoscopic Microscopy VIII, 85750S (13 March 2013); doi: 10.1117/12.2003411
Show Author Affiliations
Molly Keenan, The Univ. of Arizona (United States)
Sarah Leung, The Univ. of Arizona (United States)
Faith Rice, The Univ. of Arizona (United States)
R. Andrew Wall, The Univ. of Arizona (United States)
Jennifer K. Barton, The Univ. of Arizona (United States)

Published in SPIE Proceedings Vol. 8575:
Endoscopic Microscopy VIII
Guillermo J. Tearney M.D.; Thomas Duen-Shyr Wang, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?